Home > Insider Trading > Filing (0001127602-19-016564)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1705843	Calyxt Inc.	CLXT	Agricultural Chemicals (2870)	271967997

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1712191	F Daniel Voytas	2800 Mount Ridge Road Roseville MN 55113	Chief Science Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-29	3,750	$3.59	96,732	No	4	M	Direct
Common Stock	Disposition	2019-04-29	3,750	$16.31	92,982	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-04-29	3,750	$0.00	3,750	$3.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
204,611		2026-04-07	No	4	M	Direct

Footnotes

Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.61, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on April 7, 2016 and vested 20% on the grant date and 10% on April 7, 2017, with the remainder vesting quarterly in equal installments over the following 42 months, 25% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering.